Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial Article Early Access

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Kim, Edward S.; Velcheti, Vamsidhar; Mekhail, Tarek; Yun, Cindy; Shagan, Sarah M.; Hu, Sylvia; Chaes, Young Kwang; Leal, Ticiana A.; Dowell, Jonathan E.; Tsai, Michaela L.; Dakhil, Christopher S. R.; Stella, Philip; Jin, Yanling; Shames, David S.; Schleifman, Erica; Fabrizio, David A.; Phan, See; Socinski, Mark A.

authors

Publication Date

  • April 14, 2022

webpage

published in

category